Stanford Urologic Cancer Program — Palo Alto, California

Stanford Urologic Cancer Program is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford Urologic Cancer Program has participated in 1 clinical trials.

Therapeutic areas: Clear Cell Renal Cell Carcinoma.

Sponsors: Telix Pharmaceuticals (Innovations) Pty Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Urologic Cancer Program?

Stanford Urologic Cancer Program has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Urologic Cancer Program conducted?

Stanford Urologic Cancer Program has 1 clinical trials on record. Their work covers Clear Cell Renal Cell Carcinoma.

Is Stanford Urologic Cancer Program accredited by Crixeo Clinical Trials?

Stanford Urologic Cancer Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Urologic Cancer Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.